Early detection of and digital therapeutics for cognitive impairment
MindAhead has raised $526K in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2023.
MindAhead's investors include CDP Venture Capital, IKIGAI, RoX Health, OHA Osnabrück Healthcare Accelerator, AC75 Startup Accelerator.
MindAhead is headquartered in Berlin, Germany.
Early detection of and digital therapeutics for cognitive impairment
MindAhead is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MindAhead — Funding & Investors." VCBacked, January 5, 2023, https://www.vcbacked.co/company/mindahead. Accessed September 13, 2026.
VCBacked. (2023). MindAhead — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/mindahead
{{cite web |title=MindAhead — Funding & Investors |url=https://www.vcbacked.co/company/mindahead |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated